Advisory: Alerts on Ethos Technologies' Q2 results wrongly attributed to Atyr Pharma withdrawn
ADVISORY-Alerts on Ethos Technologies' Q2 results wrongly attributed to Atyr Pharma withdrawn Alerts on Ethos Technologies' LIFE.O second-quarter results wrongly attributed to Atyr Pharma ATYR.O were inadvertently published and have been withdrawn.
For the correct set of alerts on Ethos' Q2 earnings, click nFWN4400U6.
STORY_NUMBER: nPLX68GRR2
STORY_DATE: 03/08/2026
STORY_TIME: 08:05 PM GMT
Recent news on Ethos Technologies
See all newsU.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
J.P.Morgan downgrades Ethos Technologies to 'neutral'; shares slip
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Ethos Technologies Inc reports results for the quarter ended June 30 - Earnings Summary